Primd Pharma Private Limited
About Primd Pharma Private Limited
Data last updated:
Primd Pharma Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 08 January 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24290TG2019PTC129584. Its GSTIN is 36AAKCP2884N1ZN (Telangana).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Pratap Kumar Gondala and Snehitha Gondala.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at D No; 6 – 3 – 131/45 First Floor Shobana Colony Balanagar, Hyderabad, Telangana, India – 500037.
As per the financials filed for FY 2024, the company reported a revenue of ₹4.51 Lakh, a growth of 40% compared to the previous year. For the same year it recorded a net loss of ₹1.52 Lakh (net margin -33.7%) and EBITDA of -₹1.49 Lakh (EBITDA margin -33.1%). Revenue has grown at a compounded annual rate (CAGR) of 16% over three years.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressD No; 6 – 3 – 131/45 First Floor Shobana Colony Balanagar, Hyderabad, Telangana, India – 500037
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Primd Pharma Private Limited
The main business activity of Primd Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Primd Pharma Private Limited FY 2025 filings available
Primd Pharma Private Limited reported revenue of ₹4.51 Lakh (up 40% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR) of Primd Pharma Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 16% over three years, including 40% growth in the latest year. EBITDA fell 334% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Primd Pharma Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | -₹1.49 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | -₹1.52 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Primd Pharma Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -33.1% | •••• | •••• | •••• | •••• |
| Net Profit Margin | -33.7% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Primd Pharma are in the company report.
Financial statements from FY 2019
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Primd Pharma Private Limited
Primd Pharma Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Valleysun Pharma Private Limited | ₹4.58 Lakh (FY 2021) | •••• | •••• | •••• | Kalyan West, Maharashtra, India | |
| Rothwell Formulations Private Limited | ₹4.57 Lakh (FY 2025) | •••• | •••• | 44.0% | •••• | Mumbai, Maharashtra, India |
| RSND Formulations (OPC) Private Limited | ₹4.55 Lakh (FY 2025) | •••• | •••• | -34.0% | •••• | Mithoni, Uttar Pradesh, India |
| Biored Remedies Private Limited | ₹4.55 Lakh (FY 2025) | •••• | •••• | 98.0% | •••• | Krishnarajapuramhobli, Karnataka, India |
| VL Pharmaceuticals Private Limited | ₹4.52 Lakh (FY 2019) | •••• | •••• | 133.0% | •••• | Lucknow, Uttar Pradesh, India |
| Primd Pharma Private Limited this company | ₹4.51 Lakh (FY 2024) | •••• | •••• | 40.0% | •••• | Hyderabad, Telangana, India |
| Boots Healthcare Private Limited | ₹4.49 Lakh (FY 2024) | •••• | •••• | 8.0% | •••• | Delhi, India |
| Srivenn Formulations Private Limited | ₹4.46 Lakh (FY 2021) | •••• | •••• | •••• | Hyderabad, Telangana, India | |
| Lumina Life Sciences India Limited | ₹4.42 Lakh (FY 2018) | •••• | •••• | -33.0% | •••• | Hyderabad, Telangana, India |
| Kcureit Pharmaceutical Private Limited | ₹4.42 Lakh (FY 2022) | •••• | •••• | •••• | Panipat, Haryana, India | |
| Ampus Life Sciences Limited | ₹4.38 Lakh (FY 2025) | •••• | •••• | 69.0% | •••• | Navi Mumbai, Maharashtra, India |
Peers are the five companies nearest above and the five nearest below Primd Pharma by revenue in the Pharma industry (Formulations), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Primd Pharma Private Limited
Primd Pharma Private Limited is audited by SAMPATH SOORA & ASSOCIATES for the financial year 2021.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| SAMPATH SOORA & ASSOCIATES | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Primd Pharma Private Limited
Primd Pharma has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Pratap Kumar Gondala | Director | 08 Jan 2019 | 7 Years 9 Months | Current |
| Snehitha Gondala | Director | 08 Jan 2019 | 7 Years 9 Months | Current |
Ownership and Shareholding of Primd Pharma Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Primd Pharma Private Limited
Primd Pharma Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Primd Pharma Private Limited
Employment history and EPFO contributions of people linked to Primd Pharma.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Primd Pharma Private Limited
Primd Pharma Private Limited has 2 board changes on record since 2019: 2 appointments. The latest: Pratap Kumar Gondala was appointed as Director on 08 Jan 2019.
Credit Ratings, Litigation & Regulatory Alerts for Primd Pharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Primd Pharma Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Primd Pharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Primd Pharma Private Limited
Primd Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AAKCP2884N1ZN | Telangana | Active | 08 Jul 2019 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Primd Pharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Primd Pharma Private Limited
Primd Pharma is an active private limited company based in Hyderabad, Telangana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 08 January 2019 (7+ years old) and is registered under CIN U24290TG2019PTC129584.
Primd Pharma reported revenue of ₹4.51 Lakh for FY 2024 (up 40% YoY).
Primd Pharma has 2 current directors:
- Pratap Kumar Gondala - Director
- Snehitha Gondala - Director
Primd Pharma reported a net loss of ₹1.52 Lakh (net margin -33.7%) and EBITDA of -₹1.49 Lakh (EBITDA margin -33.1%) for FY 2024, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Primd Pharma is 16% over three years. In the latest year (FY 2024) revenue rose 40%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Primd Pharma is 36AAKCP2884N1ZN, registered in Telangana.
The CIN (Corporate Identification Number) of Primd Pharma is U24290TG2019PTC129584. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Primd Pharma was incorporated on 08 January 2019, making it 7+ years old. It is registered with the Registrar of Companies, Hyderabad.
The peers of Primd Pharma by revenue are Valleysun Pharma Private Limited, Rothwell Formulations Private Limited, RSND Formulations (OPC) Private Limited, Biored Remedies Private Limited, VL Pharmaceuticals Private Limited and 5 more, all in the Pharma industry (Formulations).
Pratap Kumar Gondala was appointed as Director on 08 Jan 2019. Snehitha Gondala was appointed as Director on 08 Jan 2019.
The registered office of Primd Pharma is at D No; 6 – 3 – 13145 First Floor Shobana Colony Balanagar, Hyderabad, Telangana, India – 500037.